Current and Emerging Diagnostic Tests Available for the novel COVID-19 global pandemic

Corona Virus Unsplash Photo

Open Letter - by Gerald Mboowa


On March 11, 2020 the World Health Organization (WHO) upgraded the status of the coronavirus disease 2019 (COVID-19) outbreak from epidemic to a global pandemic. This infection is caused by a novel coronavirus, SARS-CoV-2. Several rapid diagnostic tests have been developed at an astonishing pace; however, COVID-19 requires more highly specific rapid point-of-care diagnostic tests. This review describes the currently available testing approaches, as well as the available test assays including the Xpert® Xpress SARS-CoV-2 test (takes  45 min) and Abbott ID COVID-19 test (5 min) as easy to use point-of-care tests for diagnosis of novel COVID-19 that have so far received the US Food and Drug Administration emergency use authorizations clearance. This review is correct as of the date published and will be updated as more diagnostic tests come to light.


Coronavirus, COVID-19, diagnosis, genome sequencing, SARS-CoV-2, Point-of-Care test

This article is included in the Coronavirus (COVID-19) collection

Read full article on

Other Articles on COVID-19

March 16, 2020

IDI Hands Over PoE Equipment Worth UGX510M for Infection Control

The Minister of Health-Hon. Dr. Jane Ruth Aceng (…

Read More
March 16, 2020

Making Workplaces Ready for Coronavirus Disease (COVID-19)

Making Workplaces Ready for Coronavirus Disease (…

Read More
March 18, 2020

Uganda’s Preparedness to Prevent, Detect and Respond to the COVID-19 Pandemic

The Dean, MakSPH -Prof,Rhoda Wanyenze , The…

Read More
March 19, 2020

VC's Message Following Presidential Directive to Close Schools and Institutions

Fellow Makerereans and all our Stakeholders.…

Read More